SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (1192)6/18/2000 4:04:00 PM
From: Oak Tree  Respond to of 52153
 
Thanks Peter, I'll look into ALXN and NBIX.



To: Biomaven who wrote (1192)6/18/2000 7:20:00 PM
From: IRWIN JAMES FRANKEL  Read Replies (1) | Respond to of 52153
 
Hi Peter:

ITMN - I have been looking at this one myself. At first blush interferon gamma looks very interesting for its tendency to initiate an immune system response. But it seems like little use has so far been proven although there are some promising speculations like resistant tuberculosis.

This weekend I talked to a PHD pharmacologist who described ig as disappointing.

Any thoughts?

ij